There are 1105 resources available
694P - Chemoimmunotherapy versus pembrolizumab as a first-line treatment for patients with advanced non-small cell lung cancer and high PD-L1 expression: Focus on the role of performance status
Presenter: Tadaaki Yamada
Session: Poster Display session
Resources:
Abstract
695P - Second-line envafolimab and beyond in locally advanced or metastatic non-small cell lung cancer
Presenter: Maojing Guan
Session: Poster Display session
Resources:
Abstract
696P - Impact of local therapy on survival in patients with brain metastases from non-small cell lung cancer (NSCLC): A real-world cohort study
Presenter: Lige Wu
Session: Poster Display session
Resources:
Abstract
697P - Aumolertinib plus anlotinib as first-line treatment for EGFR mutant non-small cell lung cancer: A phase II trial (ALWAYS)
Presenter: Hua Lin Chen
Session: Poster Display session
Resources:
Abstract
698P - First-line aumolertinib in EGFR-mutant pulmonary adenosquamous carcinoma: Updated overall survival of the multicenter, single-arm, prospective study (ARISE)
Presenter: Long Zhang
Session: Poster Display session
Resources:
Abstract
699P - Osimertinib combined with chemotherapy as first-line treatment in EGFR-mutant advanced NSCLC patients: The first real-world analysis in China
Presenter: Wenxiang Ji
Session: Poster Display session
Resources:
Abstract
700P - Survival and efficacy of gefitinib plus chemotherapy versus gefitinib monotherapy on EGFR-mutant advanced non-small cell lung cancer: A systematic review and meta-analysis
Presenter: Kimberly Ismael
Session: Poster Display session
Resources:
Abstract
701P - Concordance of different immunohistochemical assays in MET protein overexpression detection in lung adenocarcinoma
Presenter: Li Liu
Session: Poster Display session
Resources:
Abstract
702P - Young and vulnerable: The alarming trends of lung cancer in young adults from India
Presenter: Pragadeesh Thamarai Selvan
Session: Poster Display session
Resources:
Abstract
703P - Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
Presenter: Yi Xiang
Session: Poster Display session
Resources:
Abstract